Bafna-Pharma. Stock/Share Prices, Buy and Sell Bafna-Pharma. BSE Stocks

Bafna Pharmaceuticals Ltd NSE / BSE
Pharmaceuticals, Small Cap

Invest

22 Apr 2019 | 12:00 AM

9.20

-0.30 (-3.16%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-67.49%

Return (1Y)

Underperformed S&P BSE Sensex by 79.67%
More Volatile

3.19%

Standard Deviation (1Y)

Higher than S&P BSE Sensex by 2.42%
Inconsistent Performer

2/12

Months

underperformed S&P BSE Sensex
AxisDirect View

No View

52 Week High-Low

News & Announcements

Bafna Pharmaceuticals standalone net profit declines 99.57% in the December 2018 quarter
72 days ago

Bafna Pharmaceuticals standalone net profit declines 99.57% in the December 2018 quarter

09 - Feb - 2019 12:00 AM | 72 days ago

Net profit of Bafna Pharmaceuticals declined 99.57% to Rs 0.12 crore in the quarter ended December 2018 as against Rs 28.09 crore during the previous quarter ended December 2017. Sales rose 20.35% to Rs 13.07 crore in the quarter ended December 2018 as against Rs 10.86 crore during the previous quarter ended December 2017.
Particulars Quarter Ended
Dec. 2018 Dec. 2017 % Var.
Sales 13.07 10.86 20
OPM % 8.95 5.06 -
PBDT 1.02 29.08 -96
PBT 0.12 28.09 -100
NP 0.12 28.09 -100
Powered by Capital Market - Live News
Bafna Pharmaceuticals to conduct board meeting
81 days ago

Bafna Pharmaceuticals to conduct board meeting

31 - Jan - 2019 12:00 AM | 81 days ago

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 8 February 2019.
Powered by Capital Market - Live News
Bafna Pharmaceuticals reports standalone net loss of Rs 1.28 crore in the September 2018 quarter
158 days ago

Bafna Pharmaceuticals reports standalone net loss of Rs 1.28 crore in the September 2018 quarter

15 - Nov - 2018 12:00 AM | 158 days ago

Net Loss of Bafna Pharmaceuticals reported to Rs 1.28 crore in the quarter ended September 2018 as against net loss of Rs 2.77 crore during the previous quarter ended September 2017. Sales declined 17.23% to Rs 8.84 crore in the quarter ended September 2018 as against Rs 10.68 crore during the previous quarter ended September 2017.
Particulars Quarter Ended
Sep. 2018 Sep. 2017 % Var.
Sales 8.84 10.68 -17
OPM % 1.92 2.62 -
PBDT -0.48 -1.80 73
PBT -1.23 -2.76 55
NP -1.28 -2.77 54
Powered by Capital Market - Live News
Bafna Pharmaceuticals announces board meeting date
161 days ago

Bafna Pharmaceuticals announces board meeting date

12 - Nov - 2018 12:00 AM | 161 days ago

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 November 2018.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

Bafna Pharmaceuticals Ltd has the Lowesr P/E ratio according to FY 201803 data among stocks in Pharmaceuticals Sector
Bafna Pharmaceuticals Ltd has the Lowesr P/B ratio according to FY 201803 data among stocks in Pharmaceuticals Sector

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2018	Dec. 2017	% Var.
Sales	13.07	10.86	20
OPM %	8.95	5.06	-
PBDT	1.02	29.08	-96
PBT	0.12	28.09	-100
NP	0.12	28.09	-100

Particulars	Quarter Ended
	Sep. 2018	Sep. 2017	% Var.
Sales	8.84	10.68	-17
OPM %	1.92	2.62	-
PBDT	-0.48	-1.80	73
PBT	-1.23	-2.76	55
NP	-1.28	-2.77	54

General Notifications

My Notifications

Research Notifications

Bafna Pharmaceuticals Ltd NSE / BSE Pharmaceuticals, Small Cap

9.20 -0.30 (-3.16%)

News & Announcements

Price vs Volume

Stock Trivia

Bafna Pharmaceuticals Ltd NSE / BSE
Pharmaceuticals, Small Cap

9.20

-0.30 (-3.16%)